<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>


<body>
<div class="uk-container">
    <div class="chapter-header">
        <div class="header-title">
            <div>
                <img src="ic_chart.svg"  class="ic_chapter_icon">
            </div>
            <p class="chapter-title">13. When to Start HIV Therapy</p>
        </div>
        <p> <span class="view-in-chapter-highlight"> View in chapter → <span> <a href="5_treatment_of_current_(active)_disease_therapy__f__tb_and_hiv.html#table13"> Antiretroviral Therapy (ART) and Treatment of Persons Living with HIV and Active TB </a></p>
        <p class="last-updated"><i>Last Updated October 2025</i></p>
    </div>
    <hr>
    <div class="uk-overflow-auto"
         id="table_13_when_to_start_hiv_therapy">
        <table class="uk-table uk-table-small uk-table-divider">
            <thead>
                <tr>
                    <th colspan="2">HHS Panel Recommendations on treatment of Tuberculosis Disease with HIV co-infection: Timing of Antiretroviral Therapy (ART) Initiation relative to TB treatment</th>
                </tr>
            </thead>
            <tr>
                <td>CD4 count and/or clinical status at time of TB diagnosis</td>
                <td>ART Initiation</td>
            </tr>
            <tr>
                <td>< 50 cells/mm³ <span class="info-icon" data-tooltip="EXCEPTION: tuberculous meningitis. To avoid life-threatening CNS immune reconstitution inflammatory syndrome (IRIS), persons living with HIV and tuberculous meningitis should not be started on ART until AFTER 8 weeks of TB therapy" data-tooltip-position="tooltip-center">i</span></td>
                <td>within 2 weeks of starting TB therapy.</td>
            </tr>
            <tr>
                <td>> 50 cells/mm³ <span class="info-icon" data-tooltip="EXCEPTION: tuberculous meningitis. To avoid life-threatening CNS immune reconstitution inflammatory syndrome (IRIS), persons living with HIV and tuberculous meningitis should not be started on ART until AFTER 8 weeks of TB therapy" data-tooltip-position="tooltip-center">i</span></td>
                <td>within 2-8 weeks of starting TB therapy</td>
            </tr>
            <tr>
                <td>Pregnant, any CD4 count</td>
                <td>As early as feasible</td>
            </tr>
        </table>
        <p>Above based on guidelines developed by the Department of Health and Human Services (DHHS) Panel on Guidelines for Use of Antiretroviral Agents for Adults and Adolescents and Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal Transmission in the United States, last reviewed and updated April 15, 2019 <br> (<a href="https://aidsinfo.nih.gov/guidelines">https://aidsinfo.nih.gov/guidelines</a>).</p>
    </div>
</div>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
<script src="main.js" type="text/javascript"></script>

</html>
